Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA005539 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA005539, RRID:AB_1078164
- Product name
- Anti-KANK1
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human KANK1, Gene description: KN motif and ankyrin repeat domains 1, Alternative Gene Names: ANKRD15, KANK, KIAA0172, Validated applications: IHC, Uniprot ID: Q14678, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.2 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Cell adhesion and spreading on fluid membranes through microtubules-dependent mechanotransduction.
Talin-KANK1 interaction controls the recruitment of cortical microtubule stabilizing complexes to focal adhesions
KANK deficiency leads to podocyte dysfunction and nephrotic syndrome
Mikhajlov O, Adar RM, Tătulea-Codrean M, Macé AS, Manzi J, Tabarin F, Battistella A, di Federico F, Joanny JF, Tran van Nhieu G, Bassereau P
Nature communications 2025 Jan 31;16(1):1201
Nature communications 2025 Jan 31;16(1):1201
Talin-KANK1 interaction controls the recruitment of cortical microtubule stabilizing complexes to focal adhesions
Bouchet B, Gough R, Ammon Y, van de Willige D, Post H, Jacquemet G, Altelaar A, Heck A, Goult B, Akhmanova A
eLife 2016;5
eLife 2016;5
KANK deficiency leads to podocyte dysfunction and nephrotic syndrome
Gee H, Zhang F, Ashraf S, Kohl S, Sadowski C, Vega-Warner V, Zhou W, Lovric S, Fang H, Nettleton M, Zhu J, Hoefele J, Weber L, Podracka L, Boor A, Fehrenbach H, Innis J, Washburn J, Levy S, Lifton R, Otto E, Han Z, Hildebrandt F
Journal of Clinical Investigation 2015;125(6):2375-2384
Journal of Clinical Investigation 2015;125(6):2375-2384
No comments: Submit comment
No validations: Submit validation data